Imatinib Terminated Phase N/A Trials for Chronic Myelogenous Leukemia (CML)

IndicationsStatusPurposePhase
TerminatedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02146846Population Pharmacokinetics of Imatinib in CML Patients in Iran